HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 517822Erstellt: 27. Oktober 2026
5-((4-Hydroxyphenyl)methylene)-2,4-thiazolidinedione
(Z)-5-(4-hydroxybenzylidene)thiazolidine-2,4-dione · Pioglitazone Impurity 42 · 5-(4-hydroxybenzylidene)-2,4-thiazolidinedione · 5-[(4-hydroxyphenyl)methylene]-2,4-Thiazolidinedione · 2,4-Thiazolidinedione, 5-[(4-hydroxyphenyl)methylene]- · (Z)-5-(4-hydroxybenzylidene)thiazolidine-2,4-dione(WX180325) · Pioglitazone impurity 5-(4-Hydroxybenzylidene)thiazolidine-2,4-dione
https://huagongshe.com/de/chemical/517822
Identifikatoren & physikalische Daten
| CAS No. | 103788-60-9 |
|---|
| Summenformel | C10H7NO3S |
|---|
| Durchschnittliche Molmasse | 221,23 g/mol |
|---|
| SMILES | O=C1NC(=O)C(=Cc2ccc(O)cc2)S1 |
|---|
| InChIKey | ARHIHDVVUHVQCP-UHFFFAOYSA-N |
|---|
| PubChem CID | 517822 |
|---|
| EC No. | 104-841-5 |
|---|
Chemische & physikalische Eigenschaften
| XLogP | 1,8 |
|---|
| Polarare Oberfläche (TPSA) | 91,7 |
|---|
| H-Brücken-Donoren | 2 |
|---|
| H-Brücken-Akzeptoren | 4 |
|---|
| Frei drehbare Bindungen | 1 |
|---|
| Schwere Atome | 15 |
|---|
| Formalladung | 0 |
|---|
| Komplexität | 319 |
|---|
Sicherheit & Vorschriften
| GHS-Einstufung | WarningH319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]P264+P265, P280, P305+P351+P338, and P337+P317 (click each P-code to see the statement)The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory. |
|---|
| Hazard Classes and Categories | Eye Irrit. 2 (100%) |
|---|
| Gefahrenklasse | IRRITANT |
|---|
Anwendungen & Verwendung
Verwenden
5-[(4-Hydroxyphenyl)methylene]-2,4-thiazolidinedione is a 5-Benzylidene-2,4-thiazolidenedione derivative designed as inhibitors of angiogenesis targeting VEGFR-2. Also, it is an intermediate used in the synthesis of MSDC 0602 (M755420), which is an analogue ofthiazolidinediones, exhibits low affinity for binding and activation of peroxisome proliferator-activated receptor γ (PPARγ). Thiazolidinediones are effective insulin-sensitizing drugs for treating various metabolic and inflammatory diseases.